Everence Capital Management Inc Illumina, Inc. Transaction History

Everence Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$92.79 - $142.53 $334,786 - $514,248	-3,608 Reduced 45.0%	4,410 $614,000
Q3 2023 Oct 16, 2023	BUY	$128.91 - $192.44 $29,649 - $44,261	230 Added 2.95%	8,018 $1.1 Million
Q4 2022 Jan 31, 2023	BUY	$187.24 - $242.74 $269,625 - $349,545	1,440 Added 22.68%	7,788 $1.58 Million
Q1 2022 Apr 11, 2022	BUY	$303.87 - $423.8 $325,140 - $453,466	1,070 Added 20.27%	6,348 $2.22 Million
Q4 2020 Feb 01, 2021	BUY	$292.7 - $370.96 $626,378 - $793,854	2,140 Added 68.2%	5,278 $1.95 Million
Q4 2019 Jan 28, 2020	SELL	$288.29 - $335.49 $32,000 - $37,239	-111 Reduced 3.42%	3,138 $1.04 Million
Q4 2017 Feb 02, 2018	BUY	$202.23 - $230.03 $296,469 - $337,223	1,466 Added 82.22%	3,249 $710,000
Q3 2017 Oct 31, 2017	BUY	$172.3 - $213.93 $307,210 - $381,437	1,783	1,783 $355,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.